Search

Your search keyword '"Parikh RR"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Parikh RR" Remove constraint Author: "Parikh RR"
78 results on '"Parikh RR"'

Search Results

1. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

2. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

3. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

4. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

5. Proton Therapy For Lymphomas: Current State Of The Art

6. Association of central arterial stiffness with atrial myopathy: the Atherosclerosis Risk in Communities (ARIC) study.

7. Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups.

8. Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.

9. Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) study.

11. Racial Differences in Nursing Home Quality of Life Among Residents Living With Alzheimer's Disease and Related Dementias.

12. Reported Unmet Hearing Aid Need in Older People With Dementia: The US National Core Indicators Survey.

13. ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy.

15. Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group.

16. Measuring Nursing Home Quality of Life: Validated Measures Are Poorly Correlated With Proxies From MDS and Quality of Life Deficiency Citationsl.

18. Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report.

19. Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations.

20. Extensive stage small cell lung cancer (ES-SCLC) and palliative care disparities: a national cancer database study.

21. Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study.

22. The Use of Monoclonal Antibody-Based Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia.

23. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.

24. Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF).

25. Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility.

26. Association of Differential Leukocyte Count With Incident Abdominal Aortic Aneurysm Over 22.5 Years: The ARIC Study.

27. Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications.

28. Consensus Statement on Proton Therapy for Prostate Cancer.

29. Feeding the Controversy: When Pelvic Irradiation Improves Outcomes in High-Risk and Very High-Risk Prostate Cancer.

30. Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma.

31. Proton versus Photon Breath-Hold Radiation for Left-Sided Breast Cancer after Breast-Conserving Surgery: A Dosimetric Comparison.

33. Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.

34. The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients.

35. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.

36. Pediatric hodgkin lymphoma: disparities in survival by race.

37. A novel approach to Verify air gap and SSD for proton radiotherapy using surface imaging.

38. Prospective study of plasma high molecular weight kininogen and prekallikrein and incidence of coronary heart disease, ischemic stroke and heart failure.

39. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer.

40. Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment.

42. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.

43. The role of radiotherapy in metastatic prostate cancer.

44. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey.

46. Primary Renal Ewing Sarcoma: A Case Report and Review of the Literature.

47. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.

48. Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.

49. Patient-reported Quality of Life After Proton Beam Therapy for Prostate Cancer: The Effect of Prostate Size.

50. Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.

Catalog

Books, media, physical & digital resources